Satoshi Ishikura

6.4k total citations · 1 hit paper
157 papers, 4.6k citations indexed

About

Satoshi Ishikura is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Satoshi Ishikura has authored 157 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pulmonary and Respiratory Medicine, 59 papers in Radiation and 48 papers in Surgery. Recurrent topics in Satoshi Ishikura's work include Advanced Radiotherapy Techniques (59 papers), Lung Cancer Diagnosis and Treatment (54 papers) and Lung Cancer Treatments and Mutations (40 papers). Satoshi Ishikura is often cited by papers focused on Advanced Radiotherapy Techniques (59 papers), Lung Cancer Diagnosis and Treatment (54 papers) and Lung Cancer Treatments and Mutations (40 papers). Satoshi Ishikura collaborates with scholars based in Japan, United States and United Kingdom. Satoshi Ishikura's co-authors include Atsushi Ohtsu, Takashi Ogino, Narikazu Boku, Manabu Muto, Keiji Nihei, Shigeaki Yoshida, Masahiro Hiraoka, Yoshinori Miyata, Kei Muro and Keiko Minashi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Satoshi Ishikura

146 papers receiving 4.5k citations

Hit Papers

Prospective Trial of Stereotactic Body Radiation Therapy ... 2015 2026 2018 2022 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Ishikura Japan 35 3.3k 2.1k 1.1k 993 751 157 4.6k
Yoshiyuki Shioyama Japan 32 2.4k 0.7× 925 0.4× 1.3k 1.2× 961 1.0× 1.1k 1.5× 234 3.9k
Joost J. Nuyttens Netherlands 34 2.6k 0.8× 1.5k 0.7× 2.1k 1.9× 1.6k 1.6× 1.2k 1.7× 165 4.7k
Hideomi Yamashita Japan 30 1.6k 0.5× 819 0.4× 996 0.9× 561 0.6× 982 1.3× 205 3.0k
B. Maciejewski Poland 25 1.9k 0.6× 1.1k 0.5× 1.2k 1.1× 960 1.0× 1.2k 1.5× 105 3.8k
Jong Hoon Kim South Korea 40 2.1k 0.6× 2.6k 1.2× 874 0.8× 2.2k 2.2× 932 1.2× 199 5.4k
Teruki Teshima Japan 27 1.6k 0.5× 744 0.3× 1.1k 1.0× 582 0.6× 874 1.2× 200 2.9k
Abraham J. Wu United States 33 2.4k 0.7× 1.2k 0.6× 839 0.8× 1.7k 1.7× 971 1.3× 234 3.8k
Vratislav Strnad Germany 30 1.2k 0.4× 1.2k 0.6× 1.4k 1.3× 859 0.9× 1.1k 1.5× 161 3.9k
Francesco Deodato Italy 26 1.2k 0.4× 823 0.4× 933 0.9× 836 0.8× 634 0.8× 230 2.5k
Riccardo Ragona Italy 28 1.3k 0.4× 871 0.4× 1.0k 0.9× 694 0.7× 647 0.9× 128 2.6k

Countries citing papers authored by Satoshi Ishikura

Since Specialization
Citations

This map shows the geographic impact of Satoshi Ishikura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Ishikura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Ishikura more than expected).

Fields of papers citing papers by Satoshi Ishikura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Ishikura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Ishikura. The network helps show where Satoshi Ishikura may publish in the future.

Co-authorship network of co-authors of Satoshi Ishikura

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Ishikura. A scholar is included among the top collaborators of Satoshi Ishikura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Ishikura. Satoshi Ishikura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
4.
Sanuki, Naoko, Tomoki Kimura, Atsuya Takeda, et al.. (2024). Final Results of a Multicenter Prospective Study of Stereotactic Body Radiation Therapy for Previously Untreated Solitary Primary Hepatocellular Carcinoma (The STRSPH Study). International Journal of Radiation Oncology*Biology*Physics. 121(4). 942–950.
5.
Nakamura, Mitsuhiro, Dejun Zhou, Hiroyuki Okamoto, et al.. (2023). A virtual audit system for intensity‐modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot study. Journal of Applied Clinical Medical Physics. 24(6). e14040–e14040. 2 indexed citations
7.
Okuno, Tatsuya, Masashi Wakabayashi, Ken Kato, et al.. (2017). Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303). International Journal of Clinical Oncology. 22(6). 1042–1049. 31 indexed citations
8.
Hojo, Hidehiro, et al.. (2015). A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer. Journal of Contemporary Brachytherapy. 2(2). 117–121. 11 indexed citations
9.
Hurkmans, Coen, Martin A. Ebert, Satoshi Ishikura, et al.. (2013). EP-1304: Harmonizing quality assurance procedures and corresponding naming conventions in clinical trials in radiotherapy. Radiotherapy and Oncology. 106. S492–S492. 1 indexed citations
10.
Melidis, Christos, J. Iżewska, Elena Fidarova, et al.. (2012). EP-1434 QUALITY ASSURANCE FOR CLINICAL TRIALS IN RADIOTHERAPY. Radiotherapy and Oncology. 103. S546–S547. 2 indexed citations
11.
Ishikura, Satoshi. (2012). Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges. General Thoracic and Cardiovascular Surgery. 60(3). 127–131. 12 indexed citations
12.
Tohyama, Naoki, Shizuka Hashimoto, Yu Kumazaki, et al.. (2011). SU-E-T-80: Development of IMRT Postal Audit Phantom Using Radiophotoluminescence Glass Dosimeter. Medical Physics. 38(6Part11). 3504–3504. 1 indexed citations
13.
Ishikura, Satoshi, et al.. (2011). JCOG Radiation Therapy Study Group: History and Achievements. Japanese Journal of Clinical Oncology. 41(11). 1241–1243. 7 indexed citations
14.
Nagata, Y., Masahiro Hiraoka, Taro Shibata, et al.. (2010). A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403). International Journal of Radiation Oncology*Biology*Physics. 78(3). S27–S28. 58 indexed citations
15.
Hiraoka, Masahiro & Satoshi Ishikura. (2007). A Japan Clinical Oncology Group Trial for Stereotactic Body Radiation Therapy of Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2(7). S115–S117. 34 indexed citations
16.
Sekine, Ikuo, Hiroshi Nokihara, Minako Sumi, et al.. (2006). Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1(8). 810–815. 38 indexed citations
17.
Yoshino, Tadashi, Shigeo Nakamura, Yoshihiro Matsuno, et al.. (2006). Epstein–Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B‐cell lymphoma. Cancer Science. 97(2). 163–166. 25 indexed citations
18.
Nishio, Teiji, Etsuo Kunieda, Hiroki Shirato, et al.. (2006). Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403). Physics in Medicine and Biology. 51(21). 5409–5417. 32 indexed citations
19.
Kokubo, Masaki, Michihide Mitsumori, Satoshi Ishikura, et al.. (2000). Results of Breast-Conserving Therapy for Early Stage Breast Cancer. American Journal of Clinical Oncology. 23(5). 499–505. 11 indexed citations
20.
Kuroda, Yoshinori, Akira Sano, Satoru Nishizawa, et al.. (1992). [MR imaging of bone metastasis].. PubMed. 52(11). 1550–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026